查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1766095

白色生物技術全球市場：未來預測（至 2032 年）—按產品類型、原料、組織類型、技術、最終用戶和地區進行分析

White Biotechnology Market Forecasts to 2032 - Global Analysis By Product (Biofuels, Biomaterials, Biochemicals and Industrial Enzymes), Source Material, Organism Types, Technologies, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球白色生物技術市場預計在 2025 年達到 3,824 億美元，到 2032 年將達到 8,224 億美元，預測期內的複合年成長率為 11.56%。

白色生物技術（有時也稱為工業生物技術）是指利用活細胞和酵素來生產永續產品和工業流程。它致力於在化學品、礦物和燃料的生產過程中，以生物基製程取代傳統的石油基製程。透過利用生質能等可再生資源，白色生物技術可以提高製程效率、降低能耗並減少環境影響。它對生質能源、紡織、農業和製藥等行業至關重要。這種環保策略鼓勵在生產過程中減少廢棄物、生物分解性並減少二氧化碳排放，所有這些都有助於循環經濟。

根據國際能源總署（IEA）的數據，現代生質能源目前佔全球所有可再生能源的50%，預計到2025年將以每年3%的速度成長。

對永續和環保生產的需求不斷增加

白色生物技術作為一種遵守嚴格環境法規和減少碳排放的方式，在工業領域越來越受歡迎。它能夠生產生物分解性的材料，從而減少長期的生態危害。消費者對綠色產品的偏好推動了生物製品市場的蓬勃發展。各國政府和組織正在資助生物技術研究、基礎設施建設和生態創新。因此，白色生物技術正逐漸成為永續工業轉型的關鍵要素。

研發成本高且監管障礙

開發創新生物技術製程需要專業人員、先進的設備和大量的測試環節。監管壁壘要求嚴格遵守安全和環境法規，這使得市場准入更加困難。取得監管部門的批准成本高且耗時。這些障礙限制了中小企業的進入，並延緩了產品的商業化。這可能會抑制創新，並限制整體市場擴張。

合成生物學和酵素工程的進展

合成生物學和酵素工程的進步使得開發能夠更永續地生產生物基產品、燃料和化學品的專用微生物成為可能。改進的酵素工程可以提高反應的選擇性和產量，從而降低成本並減少負面環境影響。此外，合成生物學加速了菌株最佳化和代謝途徑設計，使商業性生物製程更具擴充性。這些技術符合全球永續性目標，促進了從石化到可再生資源的轉變。越來越多的企業採用白色生物技術，因為它能夠提供更具成本效益和環保的製造流程。

與傳統化學製程的競爭

數十年的最佳化使傳統技術在大規模生產中更具成本效益。由於基礎設施完善，它們不需要更多資金。生技產品監管核准的不確定性是許多產業不願轉型的另一個原因。化學製程由於生產速度更快而具有競爭優勢。這使得白色生物技術難以獲得市場佔有率和更廣泛的認可。

COVID-19的影響

新冠疫情對白色生物技術市場產生了多方面的影響。雖然供應鏈中斷和勞動力短缺最初阻礙了生產和研發活動，但它也導致對永續的本地生物基產品的需求激增。人們對健康、衛生和永續性的日益關注加速了白色生物技術在製藥、食品和清潔產品領域的應用。各國政府和各行業加大了對生物基創新的投資，以確保其韌性，最終推動了長期成長，並促進了綠色生物加工技術的進步。

生醫材料預計將在預測期內實現最大幅度成長

生醫材料領域預計將在預測期內佔據最大的市場佔有率，這得益於其提供石油基材料的永續替代品。該領域正在推動生物分解性塑膠、醫療植入和包裝解決方案的創新，以符合全球環境法規。發酵和酶促製程的進步使生醫材料生產更加高效且擴充性。醫療保健、農業和消費品等行業日益成長的需求將推動市場擴張。隨著企業優先考慮環保和可再生解決方案，生醫材料將繼續推動白色生物技術應用的成長。

預計工業和製造業在預測期內將實現最高的複合年成長率。

由於生物基製程提高了生產效率，預計工業製造領域將在預測期內實現最高成長率。利用可再生原料可以減少對石化燃料的依賴，從而實現永續的製造方法。透過白色生物技術開發的酵素和微生物可以簡化化學反應，從而減少能源消耗和廢棄物產生。該產業還支持生物分解性塑膠和環保化學品的開發，以符合全球環境目標。對綠色工業解決方案日益成長的需求將繼續推動該領域的創新和投資。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於不斷成長的工業需求、政府對永續生產的激勵措施以及大規模的生物基原料供應。中國、印度和日本等國家正大力投資研發和生物精製基礎設施。日益成長的環境問題以及減少對石化產品依賴的需求正推動市場發展。快速的都市化和強勁的工業生產進一步刺激了需求，尤其是在製藥、食品和生質塑膠領域，這使得亞太地區成為未來白色生物技術擴張的關鍵樞紐。

複合年成長率最高的地區：

在預測期內，北美預計將呈現最高的複合年成長率，這得益於美國和加拿大的強勁貢獻。該地區在先進生物加工技術、專利申請和生物技術新興企業處於領先地位。對永續生物製造（尤其是生質燃料、特殊酵素和工業化學品）的監管支持和資金支持正在推動市場發展。然而，高昂的生產成本和嚴格的合規要求可能會阻礙快速擴展。成長仍在繼續，但更加穩定且研究密集，這使得北美成為白色生物技術創新而非產量擴張的領導者。

免費客製化服務

本報告的所有訂閱者均可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他公司（最多 3 家）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 簡介

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 主要研究資料
    • 二手研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 市場機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 企業之間的競爭

5. 全球白色生物技術市場（按產品）

  • 生質燃料
  • 生物材料
  • 生醫材料
  • 工業酵素

6. 全球白色生物技術市場（依原料）

  • 農業原料
  • 森林生質能
  • 工業廢棄物
  • 海洋生質能
  • 其他成分

7. 全球白色生物技術市場（依組織類型）

  • 細菌
  • 酵母菌
  • 真菌
  • 微藻類
  • 其他類型的組織

8. 全球白色生物技術市場（按技術）

  • 生物催化
  • 生物加工
  • 生物合成
  • 其他技術

第9章全球白色生物技術市場（按最終用戶）

  • 農業
  • 食品/飲料
  • 工業/製造業
  • 個人護理
  • 其他最終用戶

第 10 章全球白色生物技術市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併與收購（M&A）
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Koninklijke DSM NV
  • DuPont de Nemours, Inc.
  • BASF SE
  • Evonik Industries AG
  • Novozymes A/S
  • Corbion NV
  • Lonza Group Ltd
  • Amyris, Inc.
  • Ginkgo Bioworks
  • Kaneka Corporation
  • Akzo Nobel NV
  • Henkel AG & Co. KGaA
  • Mitsubishi Corporation
  • Cargill, Inc.
  • Archer Daniels Midland Company（ADM）
  • Fujifilm Holdings Corporation
  • BioAmber
  • Codexis, Inc.
Product Code: SMRC29951

According to Stratistics MRC, the Global White Biotechnology Market is accounted for $382.40 billion in 2025 and is expected to reach $822.40 billion by 2032 growing at a CAGR of 11.56% during the forecast period. White biotechnology, sometimes referred to as industrial biotechnology, is the process of creating sustainable products and industrial processes using live cells and enzymes. It emphasises the replacement of traditional petroleum-based procedures with bio-based processes for the production of chemicals, minerals, and fuels. White biotechnology improves process efficiency, lowers energy consumption, and lessens its impact on the environment by utilising renewable resources like biomass. It is essential to industries including bioenergy, textiles, agriculture, and pharmaceuticals. This environmentally beneficial strategy encourages waste reduction, biodegradability, and a smaller carbon footprint during manufacturing, all of which contribute to the circular economy.

According to the International Energy Agency (IEA), Modern bioenergy constitutes 50% of all renewable energy used in the world today and is expected to grow 3% per year through 2025.

Market Dynamics:

Driver:

Rising demand for sustainable and eco-friendly production

White biotechnology is becoming more and more popular among industries as a way to meet strict environmental laws and lower carbon footprints. It reduces long-term ecological harm by making it possible to produce biodegradable materials. The market for bio-manufactured items is being driven by consumers' preference for green products. Governments and organisations are sponsoring biotech research and infrastructure, as well as eco-innovations. White biotechnology is therefore emerging as a key component of sustainable industrial change.

Restraint:

High R&D costs and regulatory hurdles

Innovative biotechnological process development calls for specialised staff, sophisticated machinery, and extensive testing stages. By requiring stringent adherence to safety and environmental regulations, regulatory barriers make market entry even more difficult. Getting agency clearances can be expensive and time-consuming. These obstacles restrict the involvement of small and medium-sized businesses and postpone the commercialisation of products. Innovation may consequently stall, which would limit market expansion as a whole.

Opportunity:

Advancements in synthetic biology and enzyme engineering

Advancements in synthetic biology and enzyme engineering enable the development of specialised microbes capable of more sustainably producing bio-based products, fuels, and chemicals. Improved enzyme engineering lowers expenses and has a less negative effect on the environment by increasing reaction selectivity and yield. Additionally, strain optimisation and metabolic pathway design are accelerated by synthetic biology, increasing the scalability of commercial bioprocesses. In line with the objectives of global sustainability, these technologies facilitate the transition from petrochemical to renewable resources. Because white biotechnology offers more cost-effective and environmentally friendly manufacturing processes, companies are adopting it more and more.

Threat:

Competition from conventional chemical processes

Decades of optimisation have made these conventional techniques more cost-effective for large-scale manufacturing. Their extensive infrastructure eliminates the need for more funding. The uncertainty surrounding regulatory approvals for biotechnology products is another reason why many industries are reluctant to make the shift. Chemical processes' quicker output rates give them a competitive advantage as well. White biotechnology hence has difficulties expanding its market share and garnering broader acceptance.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the White Biotechnology Market. While supply chain disruptions and workforce shortages initially hindered production and research activities, the demand for sustainable and locally produced bio-based products surged. Increased focus on health, hygiene, and sustainability accelerated the adoption of white biotechnology in pharmaceuticals, food, and cleaning products. Governments and industries invested more in bio-based innovations to ensure resilience, ultimately fostering long-term growth and driving advancements in green bioprocessing technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials segment is expected to account for the largest market share during the forecast period by offering sustainable alternatives to petroleum-based materials. It drives innovation in biodegradable plastics, medical implants, and packaging solutions, aligning with global environmental regulations. Advancements in fermentation and enzymatic processes enhance the efficiency and scalability of biomaterial production. Increasing demand from industries such as healthcare, agriculture, and consumer goods boosts market expansion. As companies prioritize eco-friendly and renewable solutions, biomaterials continue to fuel growth in white biotechnology applications.

The industrial manufacturing segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the industrial manufacturing segment is predicted to witness the highest growth rate, due to enhanced production efficiency through bio-based processes. It reduces reliance on fossil fuels by utilizing renewable raw materials, leading to sustainable manufacturing practices. Enzymes and microbes developed through white biotechnology streamline chemical reactions, cutting down energy consumption and waste generation. This segment also supports the development of biodegradable plastics and eco-friendly chemicals, aligning with global environmental goals. Increasing demand for green industrial solutions continues to drive innovations and investments in this sector.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing industrial demand, government incentives for sustainable production, and a large bio-based feedstock supply. Countries like China, India, and Japan are investing heavily in R&D and bio-refinery infrastructure. The market benefits from rising environmental concerns and the need to reduce reliance on petrochemicals. Rapid urbanization and strong industrial output further fuel demand, particularly in pharmaceuticals, food, and bio-plastics, positioning Asia Pacific as a key hub for future white biotech expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong contributions from the United States and Canada. The region leads in advanced bioprocess technologies, patent filings, and biotech startups. Regulatory support and funding for sustainable biomanufacturing, especially in biofuels, specialty enzymes, and industrial chemicals, propel market development. However, high production costs and strict compliance requirements may hinder rapid scalability. While growth continues, it is more stable and research-intensive, making North America a leader in white biotechnology innovation rather than volume-driven expansion.

Key players in the market

Some of the key players profiled in the White Biotechnology Market include Koninklijke DSM N.V., DuPont de Nemours, Inc., BASF SE, Evonik Industries AG, Novozymes A/S, Corbion N.V., Lonza Group Ltd, Amyris, Inc., Ginkgo Bioworks, Kaneka Corporation, Akzo Nobel N.V., Henkel AG & Co. KGaA, Mitsubishi Corporation, Cargill, Inc., Archer Daniels Midland Company (ADM), Fujifilm Holdings Corporation, BioAmber and Codexis, Inc.

Key Developments:

In April 2025, DSM partnered with Inscripta to co-develop innovative well-aging skincare ingredients. Leveraging Inscripta's GenoScaler(TM) platform, the collaboration aims to engineer microbial strains for sustainable production of bio-based cosmetic actives. This partnership enhances dsm firmenich's biotech capabilities in personal care through precision strain development and green manufacturing.

In September 2024, DuPont and Royal DSM established a 50/50 joint venture named Actamax Surgical Materials LLC to develop and commercialize innovative biodegradable hydrogel-based biomedical materials. These include surgical sealants, tissue adhesives, and adhesion barriers aimed at enhancing patient outcomes, minimizing surgical complications, and supporting advanced wound management solutions.

In June 2024, BASF and Saarland, Marburg & Kaiserslautern Universities launched a joint research project using Basfia succiniciproducens to convert sugar and CO2 into bio-based fumaric acid-an important intermediate in the chemical industry.

Products Covered:

  • Biofuels
  • Biomaterials
  • Biochemicals
  • Industrial Enzymes
  • Other Products

Source Materials Covered:

  • Agricultural Feedstock
  • Forest Biomass
  • Industrial Waste
  • Marine Biomass
  • Other Source Materials

Organism Types Covered:

  • Bacteria
  • Yeast
  • Fungi
  • Microalgae
  • Other Organism Types

Technologies Covered:

  • Biocatalysis
  • Bioprocessing
  • Biosynthesis
  • Other Technologies

End Users Covered:

  • Agriculture
  • Food & Beverage
  • Industrial Manufacturing
  • Personal Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global White Biotechnology Market, By Product

  • 5.1 Introduction
  • 5.2 Biofuels
  • 5.3 Biomaterials
  • 5.4 Biochemicals
  • 5.5 Industrial Enzymes

6 Global White Biotechnology Market, By Source Material

  • 6.1 Introduction
  • 6.2 Agricultural Feedstock
  • 6.3 Forest Biomass
  • 6.4 Industrial Waste
  • 6.5 Marine Biomass
  • 6.6 Other Source Materials

7 Global White Biotechnology Market, By Organism Types

  • 7.1 Introduction
  • 7.2 Bacteria
  • 7.3 Yeast
  • 7.4 Fungi
  • 7.5 Microalgae
  • 7.6 Other Organism Types

8 Global White Biotechnology Market, By Technologies

  • 8.1 Introduction
  • 8.2 Biocatalysis
  • 8.3 Bioprocessing
  • 8.4 Biosynthesis
  • 8.5 Other Technologies

9 Global White Biotechnology Market, By End User

  • 9.1 Introduction
  • 9.2 Agriculture
  • 9.3 Food & Beverage
  • 9.4 Industrial Manufacturing
  • 9.5 Personal Care
  • 9.6 Other End Users

10 Global White Biotechnology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Koninklijke DSM N.V.
  • 12.2 DuPont de Nemours, Inc.
  • 12.3 BASF SE
  • 12.4 Evonik Industries AG
  • 12.5 Novozymes A/S
  • 12.6 Corbion N.V.
  • 12.7 Lonza Group Ltd
  • 12.8 Amyris, Inc.
  • 12.9 Ginkgo Bioworks
  • 12.10 Kaneka Corporation
  • 12.11 Akzo Nobel N.V.
  • 12.12 Henkel AG & Co. KGaA
  • 12.13 Mitsubishi Corporation
  • 12.14 Cargill, Inc.
  • 12.15 Archer Daniels Midland Company (ADM)
  • 12.16 Fujifilm Holdings Corporation
  • 12.17 BioAmber
  • 12.18 Codexis, Inc.

List of Tables

  • Table 1 Global White Biotechnology Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global White Biotechnology Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global White Biotechnology Market Outlook, By Biofuels (2024-2032) ($MN)
  • Table 4 Global White Biotechnology Market Outlook, By Biomaterials (2024-2032) ($MN)
  • Table 5 Global White Biotechnology Market Outlook, By Biochemicals (2024-2032) ($MN)
  • Table 6 Global White Biotechnology Market Outlook, By Industrial Enzymes (2024-2032) ($MN)
  • Table 7 Global White Biotechnology Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 8 Global White Biotechnology Market Outlook, By Source Material (2024-2032) ($MN)
  • Table 9 Global White Biotechnology Market Outlook, By Agricultural Feedstock (2024-2032) ($MN)
  • Table 10 Global White Biotechnology Market Outlook, By Forest Biomass (2024-2032) ($MN)
  • Table 11 Global White Biotechnology Market Outlook, By Industrial Waste (2024-2032) ($MN)
  • Table 12 Global White Biotechnology Market Outlook, By Marine Biomass (2024-2032) ($MN)
  • Table 13 Global White Biotechnology Market Outlook, By Other Source Materials (2024-2032) ($MN)
  • Table 14 Global White Biotechnology Market Outlook, By Organism Type (2024-2032) ($MN)
  • Table 15 Global White Biotechnology Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 16 Global White Biotechnology Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 17 Global White Biotechnology Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 18 Global White Biotechnology Market Outlook, By Microalgae (2024-2032) ($MN)
  • Table 19 Global White Biotechnology Market Outlook, By Other Organism Types (2024-2032) ($MN)
  • Table 20 Global White Biotechnology Market Outlook, By Technology (2024-2032) ($MN)
  • Table 21 Global White Biotechnology Market Outlook, By Biocatalysis (2024-2032) ($MN)
  • Table 22 Global White Biotechnology Market Outlook, By Bioprocessing (2024-2032) ($MN)
  • Table 23 Global White Biotechnology Market Outlook, By Biosynthesis (2024-2032) ($MN)
  • Table 24 Global White Biotechnology Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 25 Global White Biotechnology Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global White Biotechnology Market Outlook, By Agriculture (2024-2032) ($MN)
  • Table 27 Global White Biotechnology Market Outlook, By Food & Beverage (2024-2032) ($MN)
  • Table 28 Global White Biotechnology Market Outlook, By Industrial Manufacturing (2024-2032) ($MN)
  • Table 29 Global White Biotechnology Market Outlook, By Personal Care (2024-2032) ($MN)
  • Table 30 Global White Biotechnology Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.